Keystone Financial Planning’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
Keystone Financial Planning's NVO Position: Q3 2026 in Review
Keystone Financial Planning held its Novo Nordisk (NVO) position steady in Q3 2026 at 7,014 shares worth $266K. The position accounts for 0.07% of the portfolio, ranked #38.
Keystone Financial Planning first reported a position in NVO in Q4 2013 and has held it in 4 quarters since. The position peaked at $336K in Q2 2026. 1,237 funds tracked by Wall St. Rank hold NVO as of Q3 2026.
- Keystone Financial Planning held 7,014 shares of Novo Nordisk worth $266K as of Q3 2026.
- Keystone Financial Planning left its Novo Nordisk share count unchanged in Q3 2026.
- Novo Nordisk made up 0.07% of Keystone Financial Planning's portfolio in Q3 2026, its #38 holding.
- Keystone Financial Planning first reported a position in Novo Nordisk in Q4 2013 and has held it in 4 quarters since.
- Keystone Financial Planning's Novo Nordisk position peaked at $336K in Q2 2026.
- 1,237 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.
Based on Keystone Financial Planning's 13F filing for Q3 2026, filed 8 Oct 2026.